SRBT Stock Overview

Operates as a project management and executive consulting company. More details

SRBT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Latest financial reports are more than a year old

Does not have a meaningful market cap ($281K)

My Notes

Capture your thoughts, links and company narrative

Shanrong Biotechnology Corp. Competitors

DUKE Robotics

OTCPK:DUKR

US$12.2m

Air Industries Group

NYSEAM:AIRI

US$14.2m

Silynxcom

NYSEAM:SYNX

US$21.1m

SIFCO Industries

NYSEAM:SIF

US$24.1m

Price History & Performance

Summary of share price highs, lows and changes for Shanrong Biotechnology
Historical stock prices
Current Share Price	US$0.58
52 Week High	US$3.83
52 Week Low	US$0.094
Beta	0
1 Month Change	504.17%
3 Month Change	n/a
1 Year Change	-27.39%
3 Year Change	38.06%
5 Year Change	96.61%
Change since IPO	-99.61%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SRBT	US Aerospace & Defense	US Market
7D	-79.9%	-0.2%	1.2%
1Y	-27.4%	30.4%	21.0%

Return vs Industry: SRBT underperformed the US Aerospace & Defense industry which returned 30.4% over the past year.

Return vs Market: SRBT underperformed the US Market which returned 21% over the past year.

Price Volatility

Is SRBT's price volatile compared to industry and market?
SRBT volatility
SRBT Average Weekly Movement	n/a
Aerospace & Defense Industry Average Movement	6.6%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: SRBT's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine SRBT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Timothy Ringgold	n/a

Shanrong Biotechnology Corp. operates as a project management and executive consulting company. The company refurbishes and upgrades armored vehicles with digital communications, as well as provides spare parts and equipment for military and police forces; and offers onsite maintenance, maintenance training, operator training, and tactical training services. It also conducts program management, business development, and strategic studies and analyses in the defense, homeland security, information technology, and telecommunications markets.

Shanrong Biotechnology Corp. Fundamentals Summary

How do Shanrong Biotechnology's earnings and revenue compare to its market cap?
SRBT fundamental statistics
Market cap	US$281.21k
Earnings (TTM)	-US$2.07k
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is SRBT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SRBT income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$2.07k
Earnings	-US$2.07k

Last Reported Earnings

Dec 31, 2015

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did SRBT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 01:49
End of Day Share Price	2025/02/10 00:00
Earnings	2015/12/31
Annual Earnings	2015/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shanrong Biotechnology Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.